News + Filings Holdings
All
13F
13D/G
Other
|
|
EVENTIDE ASSET MANAGEMENT, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 11.1% stake in Zentalis Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.6% stake in Mirum Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.6% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.3% stake in Aura Biosciences, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7% stake in 908 Devices Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.1% stake in Zymeworks Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.7% stake in VectivBio Holding AG |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.6% stake in Prometheus Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.8% stake in Cogent Biosciences, Inc. |
| 02/10/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 10.1% stake in KnowBe4, Inc. |
| 02/12/2021 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.2% stake in Vital Farms, Inc. |
| 02/12/2021 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.2% stake in Praxis Precision Medicines, Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in Freeline Therapeutics Holdings plc |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.3% stake in Annexon, Inc. |
| 02/04/2020 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.4% stake in Zogenix, Inc. |
| 02/04/2020 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.3% stake in Stemline Therapeutics, Inc. |
| 08/30/2019 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.7% stake in ESSA Pharma Inc. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2019 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8% stake in Magenta Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.7% stake in Entasis Therapeutics Holdings Inc. |
| 02/13/2019 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.6% stake in ARYA Sciences Acquisition Corp. |
| 02/12/2018 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.6% stake in KalVista Pharmaceuticals, Inc. |
| 02/12/2018 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.6% stake in Sunesis Pharmaceuticals, Inc. |
| 02/12/2018 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.1% stake in Vical Incorporated |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2017 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.3% stake in Essa Pharma, Inc. |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/12/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|